AORT Stock Analysis: Buy, Sell, or Hold?
AORT - Artivion, Inc.
$26.77
0.10 (0.37%)
â˛
5d:
-4.67%
30d:
-3.25%
90d:
+20.64%
WAIT
LOW Confidence
Analysis Updated: Aug 28, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When AORT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: AORT is fairly priced but lacks strong directional signals. At -2.8% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: AORT is fairly priced but lacks strong directional signals. At -2.8% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$38.06
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$23.63
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AORT is currently trading at $26.77, which is considered fair relative to its 30-day fair value range of $25.95 to $28.30. The stock's valuation (Forward PE: 34.2) is in line with its historical norms (37.3). Remarkably, the market is currently pricing in an annual earnings decline of 2.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AORT is in a downtrend. The price is currently testing key support at $26.02. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AORT scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $42.15 (+57.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AORT is in a downtrend. The price is currently testing key support at $26.02. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: AORT scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $42.15 (+57.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$25.95 -
$28.30
Company Quality Score
42/100
(HOLD)
Options IV Signal
54th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
53.8%
Protect Your Profits
Holding AORT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 54th percentile)
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 57.5% below Wall St target ($42.15)
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$25.95 -
$28.30
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$2.79
(10.4%)
Support & Resistance Levels
Support Level
$26.02
Resistance Level
$30.14
Current Trend
Downtrend
Technical data as of
Aug 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
34.25
Wall Street Target
$42.15
(+57.5%)
Revenue Growth (YoY)
11.3%
Profit Margin
-0.7%
Valuation Discount vs History
-2.8% cheaper
PE vs Historical
34.3 vs 37.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.8%
(market-implied from PE analysis)
1-Year Target
$26.02
(-3%)
2-Year Target
$25.29
(-6%)
3-Year Target
$24.58
(-8%)
3-Yr Target (if PE normalizes)
(PE: 34â37)
$26.78
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 34.2, Growth: 77.0%)
$90.35
(+238%)
Base:
(SPY PE: 20.1, Growth: 77.0%)
$52.95
(+98%)
Bear:
(PE: 17.1, Growth: 77.0%)
$45.01
(+68%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 34.2 to 37.3
Stabilization Target:
$29.16
(+8.9%)
PE Expansion Potential:
+8.9%
Share & Embed Analysis
Last updated: August 29, 2026 4:38 PM ET
Data refreshes hourly during market hours. Next update: 5:38 PM
Data refreshes hourly during market hours. Next update: 5:38 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AORT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Jean F Holloway
SELL
8962 shares
2026-03-04
Marshall S Stanton
SELL
2149 shares
2026-03-03
Lance A Berry
SELL
6316 shares
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 48 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 56 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 67 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 43 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 49 HOLD |
Advanced AORT Option Strategies
Professional options setups generated by AI based on today's AORT price and gamma walls.
